AAMI Surveys Cardiac Health Professionals on Battery Longevity Management of Pacemakers Ready to Announce with Confidence?
Arlington, Virginia--(Newsfile Corp. - July 28, 2026) - The Association for the Advancement of Medical Instrumentation (AAMI) officially announces the publication of a new guidance document on battery longevity management for implantable cardiac pacemakers and related devices.
Given the limits of existing industry standards for cardiovascular implantable electronic device safety, there is significant variation among devices and in how manufacturers convey longevity information to clinicians.
A new Technical Information Report (TIR) from AAMI aims to help address this discrepancy. AAMI TIR107:2026; Cardiovascular implantable electronic devices-Battery longevity management and reporting and prolonged service period behavior collects survey data from clinicians who specialize in cardiac health and work with devices such as pacemakers and implantable cardiac resynchronization devices that use non-rechargeable batteries. Survey respondents included members of the Heart Rhythm Society, the AAMI Cardiac Rhythm Management Devices Committee, and individual cardiologists and electrophysiologists. Of the clinicians surveyed:
AAMI's Cardiac Rhythm Management Devices Committee developed TIR107. At the time of publication, the Committee was composed of volunteer experts from regulatory agencies, health care delivery organizations, and medical device manufacturers. The committee was co-chaired by Shiloh Sison, Sr. Associate Research Fellow at Abbott Laboratories, and Dr. Charles Love, Director of the Johns Hopkins Cardiac Rhythm Device Service.
Sison described TIR107 as an important source of "clinician input into battery longevity management and reporting, and prolonged service period behavior." This input is a critical resource for firms that produce medical devices and is "needed by manufacturers to inform future device designs."
The document is limited in scope to pacemakers, implantable devices that treat tachyarrhythmia, and implantable cardiac resynchronization devices that use non-rechargeable batteries. AAMI TIR107 does not apply to implantable cardiac monitors, intracardiac or leadless pacemakers, and extravascular defibrillators.
Media contact:
Daniel Visnovsky
Phone number: 703-215-8483
Email: dvisnovsky@aami.org
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306723
Source: Association for the Advancement of Medical Instrumentation
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Association for the Advancement of Medical Instrumentation or all companies in the Health industry.
AAMI Surveys Cardiac Health Professionals on Battery Longevity Management of Pacemakers
2026-07-28 8:50 AM EDT
AAMI Updates Standard for Manufacturers of Medtech Steam Sterilization Systems
2026-07-14 8:55 AM EDT
AAMI Returns to Costa Rica with Advanced QMSR Course for Medical Device Professionals
2026-06-25 8:50 AM EDT
Apr 23, 2026
Disclosure Intelligence Series How disclosure works in modern capital markets Most companies treat a U.S. stock exchange listing as a structural milestone. In practice, it represents something more significant. Entering U.S. markets is not just a listing event. It is a fundamental shift in how a company’s information is communicated, interpreted, and acted on. As of March 2026, 187 TSX and TSX Venture issuers are interlisted on U.S. exchanges, within a broader group of 258 interlisted...
Health
Health